It also depends on who is receiving the treatment, why its being used, the quality of the product, how its administered, and whether its being used as part of an appropriate medical plan
Unlimited provider access
Many individuals may experience the most significant weight loss in the first few months
Red flags to watch for No COA available
Mechanism Avg % weight loss (placebo subtracted) Dosing Side effects Cost Semaglutide GLP-1 receptor agonist : (increases insulin secretion, suppresses appetite, enhances satiety, slows gastric emptying) STEP 1 14.9% (68 weeks) STEP 5 (120 weeks): -16.5% ~1517% average sustained loss 20% loss in ~17% of users 2.4mg weekly Nausea (44%) Diarrhea (30%) Vomiting (24%) Constipation (23%) Headache, fatigue Varies widely but generally the cheaper of the two
Retatrutide is exciting, but it is still in trials, and its long-term impact remains unknown